SBC Medical Group Holdings Incorporated
General ticker "SBC" information:
- Sector: Industrials
- Industry: Consulting Services
- Capitalization: $426.5M (TTM average)
SBC Medical Group Holdings Incorporated does not follow the US Stock Market performance with the rate: -22.6%.
Estimated limits based on current volatility of 3.4%: low 2.91$, high 3.17$
Factors to consider:
- Earnings for 3 months up through Q1 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.09$, 5.93$]
- 2026-12-31 to 2027-12-31 estimated range: [3.57$, 6.56$]
Financial Metrics affecting the SBC estimates:
- Positive: with PPE of 8.9 at the end of fiscal year the price was very low
- Positive: Operating profit margin, % of 38.87 > 18.38
- Positive: 6.65 < Operating cash flow per share per price, % of 8.64
- Negative: Inventory ratio change, % of 1.41 > 0.80
- Positive: Shareholder equity ratio, % of 65.26 > 64.15
- Negative: -0.16 < Industry inventory ratio change (median), % of 0
- Positive: -9.33 < Industry operating profit margin (median), % of 1.31
- Negative: 0.01 < Interest expense per share per price, % of 0.04
Short-term SBC quotes
Long-term SBC plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $193.54MM | $205.42MM | $173.61MM |
| Operating Expenses | $122.88MM | $135.11MM | $106.12MM |
| Operating Income | $70.66MM | $70.30MM | $67.49MM |
| Non-Operating Income | $2.92MM | $3.15MM | $14.58MM |
| Interest Expense | $0.05MM | $0.03MM | $0.16MM |
| Income(Loss) | $73.58MM | $73.46MM | $82.07MM |
| Taxes | $35.02MM | $26.77MM | $31.02MM |
| Profit(Loss)* | $39.37MM | $46.61MM | $50.99MM |
| Stockholders Equity | $142.16MM | $195.11MM | $248.28MM |
| Inventory | $3.09MM | $1.49MM | $2.79MM |
| Assets | $258.81MM | $266.08MM | $380.45MM |
| Operating Cash Flow | $-2.13MM | $20.58MM | $38.92MM |
| Capital expenditure | $11.21MM | $3.41MM | $2.37MM |
| Investing Cash Flow | $101.01MM | $-10.10MM | $-20.97MM |
| Financing Cash Flow | $-99.08MM | $22.97MM | $24.04MM |
| Earnings Per Share** | $0.42 | $0.48 | $0.50 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.